This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated COL5A1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-COL5A1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~183.6 kDa | |
| Gel | 8–10% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Cleaved | |
| Caveat | Processing-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 2 isoform(s) |
The A02283-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | C6 (40ug), CT26 (40ug), U-87MG (40ug) (catalog A02283-1) |
| Gel % | 8–10% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Wet/tank transfer; optimize duration (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A02283-1; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
COL5A1 has a predicted 183.6 kDa precursor; processing and chain association could affect migration, but no empirical band size demonstrates their effects.
| Band near 183.6 kDa | Compatible with the predicted full-length precursor; confirm identity with controls |
| Band below 183.6 kDa | May reflect signal-peptide or C-terminal propeptide cleavage |
| Higher band under non-reducing conditions | May reflect retained collagen chain association |
| Little or no band in whole-cell lysate | COL5A1 is secreted into the extracellular matrix |
| Several bands at different positions | May reflect processing or isoforms 1 and 2; distinct isoform migration is unproven |
| UniProt full-length precursor mass | Predicts 183.6 kDa before processing |
| Signal peptide at residues 1–37 | Cleavage can reduce the mature chain's mass |
| C-terminal propeptide at residues 1606–1838 | Cleavage can reduce the mature chain's mass |
| Isoforms 1 and 2 | May differ in size; their masses and migration are unspecified |
| Disulfides in collagen trimers | Retained chain association may produce a higher band under non-reducing conditions |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | COL5A1 is secreted into the extracellular matrix | Check conditioned medium or extracellular matrix fractions with a positive control |
| Band higher than expected | Collagen chains may remain associated under non-reducing or incomplete reduction conditions | Compare reducing and non-reducing samples and verify band identity |
| Band lower than expected | Signal-peptide or C-terminal propeptide cleavage may reduce chain mass | Check whether the antibody recognizes the retained region and compare precursor and processed samples |
| Multiple bands | Processing or isoforms 1 and 2 may contribute | Compare samples and verify each band's identity with an independent antibody or knockdown |
| Weak or no signal | Secreted COL5A1 may be scarce in the tested fraction | Test an extracellular matrix fraction alongside a positive control |
| Fragments below expected size | Propeptide cleavage or further proteolysis may produce shorter species | Verify antibody epitope and compare sample preparation conditions |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for COL5A1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
A02283-1 is an anti-COL5A1 antibody listed for human, mouse, and rat. Its WB image shows C6, CT26, U-87MG, and HeLa whole-cell lysates at 40 µg per lane, using a 1:500 antibody dilution. These examples do not establish performance in every sample.
Which to pick: A02283-1 is the only listed option. Check its stated reactivity against your species and compare your sample with the four lysates shown in its WB image.